nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—Parkinson's disease—Diphenhydramine—allergic rhinitis	0.643	1	CpDpCtD
L-DOPA—DRD2—Cyproheptadine—allergic rhinitis	0.0711	0.472	CbGbCtD
L-DOPA—CYP2D6—Desloratadine—allergic rhinitis	0.0339	0.225	CbGbCtD
L-DOPA—CYP2D6—Loratadine—allergic rhinitis	0.0195	0.129	CbGbCtD
L-DOPA—CYP2D6—Diphenhydramine—allergic rhinitis	0.0195	0.129	CbGbCtD
L-DOPA—CYP2D6—Dexamethasone—allergic rhinitis	0.00673	0.0447	CbGbCtD
L-DOPA—PSIP1—eye—allergic rhinitis	0.00246	0.1	CbGeAlD
L-DOPA—PSIP1—bronchus—allergic rhinitis	0.00222	0.0902	CbGeAlD
L-DOPA—PSIP1—trachea—allergic rhinitis	0.00199	0.081	CbGeAlD
L-DOPA—DDC—respiratory system—allergic rhinitis	0.00154	0.0625	CbGeAlD
L-DOPA—PSIP1—lung—allergic rhinitis	0.00143	0.0582	CbGeAlD
L-DOPA—SLC7A8—skin of body—allergic rhinitis	0.00141	0.0574	CbGeAlD
L-DOPA—SLC7A5—respiratory system—allergic rhinitis	0.00138	0.056	CbGeAlD
L-DOPA—SLC7A5—eye—allergic rhinitis	0.00126	0.0511	CbGeAlD
L-DOPA—SLC7A5—epithelium—allergic rhinitis	0.00115	0.0468	CbGeAlD
L-DOPA—SLC7A5—bronchus—allergic rhinitis	0.00113	0.0461	CbGeAlD
L-DOPA—SLC7A5—skin of body—allergic rhinitis	0.0011	0.0445	CbGeAlD
L-DOPA—SLC7A5—trachea—allergic rhinitis	0.00102	0.0414	CbGeAlD
L-DOPA—SLC15A1—epithelium—allergic rhinitis	0.000956	0.0388	CbGeAlD
L-DOPA—SLC7A8—lung—allergic rhinitis	0.000944	0.0383	CbGeAlD
L-DOPA—SLC16A10—epithelium—allergic rhinitis	0.000882	0.0358	CbGeAlD
L-DOPA—DDC—lung—allergic rhinitis	0.000817	0.0332	CbGeAlD
L-DOPA—SLC7A5—lung—allergic rhinitis	0.000732	0.0297	CbGeAlD
L-DOPA—SLC7A5—Desoximetasone—Flunisolide—allergic rhinitis	0.000686	0.223	CbGdCrCtD
L-DOPA—DRD2—respiratory system—allergic rhinitis	0.000668	0.0271	CbGeAlD
L-DOPA—DRD2—eye—allergic rhinitis	0.00061	0.0248	CbGeAlD
L-DOPA—SLC16A10—lung—allergic rhinitis	0.00056	0.0228	CbGeAlD
L-DOPA—PSIP1—Levonorgestrel—Hydrocortisone—allergic rhinitis	0.000411	0.134	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Hydrocortisone—allergic rhinitis	0.000356	0.116	CbGdCrCtD
L-DOPA—DRD2—lung—allergic rhinitis	0.000355	0.0144	CbGeAlD
L-DOPA—SLC7A5—Desoximetasone—Methylprednisolone—allergic rhinitis	0.000336	0.109	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Betamethasone—allergic rhinitis	0.00033	0.108	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Dexamethasone—allergic rhinitis	0.00033	0.108	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Triamcinolone—allergic rhinitis	0.000323	0.105	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Prednisolone—allergic rhinitis	0.000299	0.0973	CbGdCrCtD
L-DOPA—Haemorrhage—Prednisolone—allergic rhinitis	0.000137	0.000766	CcSEcCtD
L-DOPA—Dizziness—Flunisolide—allergic rhinitis	0.000136	0.000763	CcSEcCtD
L-DOPA—Haemoglobin—Hydrocortisone—allergic rhinitis	0.000134	0.000752	CcSEcCtD
L-DOPA—Haemorrhage—Hydrocortisone—allergic rhinitis	0.000134	0.000748	CcSEcCtD
L-DOPA—Vomiting—Cetirizine—allergic rhinitis	0.000133	0.000746	CcSEcCtD
L-DOPA—Hallucination—Hydrocortisone—allergic rhinitis	0.000133	0.000744	CcSEcCtD
L-DOPA—Nausea—Loratadine—allergic rhinitis	0.000132	0.000741	CcSEcCtD
L-DOPA—Rash—Cetirizine—allergic rhinitis	0.000132	0.00074	CcSEcCtD
L-DOPA—Dermatitis—Cetirizine—allergic rhinitis	0.000132	0.000739	CcSEcCtD
L-DOPA—Headache—Cetirizine—allergic rhinitis	0.000131	0.000735	CcSEcCtD
L-DOPA—Vomiting—Flunisolide—allergic rhinitis	0.000131	0.000734	CcSEcCtD
L-DOPA—Rash—Flunisolide—allergic rhinitis	0.00013	0.000728	CcSEcCtD
L-DOPA—Dermatitis—Flunisolide—allergic rhinitis	0.00013	0.000727	CcSEcCtD
L-DOPA—Weight increased—Betamethasone—allergic rhinitis	0.00013	0.000727	CcSEcCtD
L-DOPA—Weight increased—Dexamethasone—allergic rhinitis	0.00013	0.000727	CcSEcCtD
L-DOPA—Hypersensitivity—Montelukast—allergic rhinitis	0.00013	0.000725	CcSEcCtD
L-DOPA—Headache—Flunisolide—allergic rhinitis	0.000129	0.000723	CcSEcCtD
L-DOPA—Weight decreased—Betamethasone—allergic rhinitis	0.000129	0.000722	CcSEcCtD
L-DOPA—Weight decreased—Dexamethasone—allergic rhinitis	0.000129	0.000722	CcSEcCtD
L-DOPA—Haemoglobin—Triamcinolone—allergic rhinitis	0.000126	0.000708	CcSEcCtD
L-DOPA—Haemoglobin—Methylprednisolone—allergic rhinitis	0.000126	0.000706	CcSEcCtD
L-DOPA—Rhinitis—Triamcinolone—allergic rhinitis	0.000126	0.000706	CcSEcCtD
L-DOPA—Asthenia—Montelukast—allergic rhinitis	0.000126	0.000706	CcSEcCtD
L-DOPA—Rhinitis—Methylprednisolone—allergic rhinitis	0.000126	0.000705	CcSEcCtD
L-DOPA—Haemorrhage—Triamcinolone—allergic rhinitis	0.000126	0.000704	CcSEcCtD
L-DOPA—Haemorrhage—Methylprednisolone—allergic rhinitis	0.000126	0.000703	CcSEcCtD
L-DOPA—Acute coronary syndrome—Dexamethasone—allergic rhinitis	0.000125	0.000702	CcSEcCtD
L-DOPA—Acute coronary syndrome—Betamethasone—allergic rhinitis	0.000125	0.000702	CcSEcCtD
L-DOPA—Hallucination—Methylprednisolone—allergic rhinitis	0.000125	0.000699	CcSEcCtD
L-DOPA—Neuropathy peripheral—Dexamethasone—allergic rhinitis	0.000125	0.000698	CcSEcCtD
L-DOPA—Neuropathy peripheral—Betamethasone—allergic rhinitis	0.000125	0.000698	CcSEcCtD
L-DOPA—Myocardial infarction—Betamethasone—allergic rhinitis	0.000125	0.000698	CcSEcCtD
L-DOPA—Myocardial infarction—Dexamethasone—allergic rhinitis	0.000125	0.000698	CcSEcCtD
L-DOPA—Nausea—Cetirizine—allergic rhinitis	0.000125	0.000697	CcSEcCtD
L-DOPA—Pruritus—Montelukast—allergic rhinitis	0.000124	0.000696	CcSEcCtD
L-DOPA—Nausea—Flunisolide—allergic rhinitis	0.000122	0.000686	CcSEcCtD
L-DOPA—Arrhythmia—Prednisolone—allergic rhinitis	0.000122	0.000684	CcSEcCtD
L-DOPA—Diarrhoea—Montelukast—allergic rhinitis	0.00012	0.000673	CcSEcCtD
L-DOPA—Arrhythmia—Hydrocortisone—allergic rhinitis	0.000119	0.000668	CcSEcCtD
L-DOPA—Mental disorder—Hydrocortisone—allergic rhinitis	0.000117	0.000655	CcSEcCtD
L-DOPA—Dizziness—Montelukast—allergic rhinitis	0.000116	0.000651	CcSEcCtD
L-DOPA—Haemoglobin—Dexamethasone—allergic rhinitis	0.000115	0.000642	CcSEcCtD
L-DOPA—Haemoglobin—Betamethasone—allergic rhinitis	0.000115	0.000642	CcSEcCtD
L-DOPA—Haemorrhage—Dexamethasone—allergic rhinitis	0.000114	0.000639	CcSEcCtD
L-DOPA—Haemorrhage—Betamethasone—allergic rhinitis	0.000114	0.000639	CcSEcCtD
L-DOPA—Hallucination—Dexamethasone—allergic rhinitis	0.000114	0.000636	CcSEcCtD
L-DOPA—Hallucination—Betamethasone—allergic rhinitis	0.000114	0.000636	CcSEcCtD
L-DOPA—Arrhythmia—Triamcinolone—allergic rhinitis	0.000112	0.000629	CcSEcCtD
L-DOPA—Vision blurred—Prednisolone—allergic rhinitis	0.000112	0.000628	CcSEcCtD
L-DOPA—Arrhythmia—Methylprednisolone—allergic rhinitis	0.000112	0.000628	CcSEcCtD
L-DOPA—Vomiting—Montelukast—allergic rhinitis	0.000112	0.000626	CcSEcCtD
L-DOPA—Rash—Montelukast—allergic rhinitis	0.000111	0.000621	CcSEcCtD
L-DOPA—Dermatitis—Montelukast—allergic rhinitis	0.000111	0.00062	CcSEcCtD
L-DOPA—Ill-defined disorder—Prednisolone—allergic rhinitis	0.00011	0.000619	CcSEcCtD
L-DOPA—Headache—Montelukast—allergic rhinitis	0.00011	0.000617	CcSEcCtD
L-DOPA—Mental disorder—Methylprednisolone—allergic rhinitis	0.00011	0.000616	CcSEcCtD
L-DOPA—Angioedema—Prednisolone—allergic rhinitis	0.000109	0.000609	CcSEcCtD
L-DOPA—Ill-defined disorder—Hydrocortisone—allergic rhinitis	0.000108	0.000604	CcSEcCtD
L-DOPA—Malaise—Prednisolone—allergic rhinitis	0.000107	0.000601	CcSEcCtD
L-DOPA—Dysgeusia—Triamcinolone—allergic rhinitis	0.000107	0.000601	CcSEcCtD
L-DOPA—Syncope—Prednisolone—allergic rhinitis	0.000107	0.000598	CcSEcCtD
L-DOPA—Angioedema—Hydrocortisone—allergic rhinitis	0.000106	0.000595	CcSEcCtD
L-DOPA—Back pain—Triamcinolone—allergic rhinitis	0.000106	0.000593	CcSEcCtD
L-DOPA—Malaise—Hydrocortisone—allergic rhinitis	0.000105	0.000587	CcSEcCtD
L-DOPA—Loss of consciousness—Prednisolone—allergic rhinitis	0.000105	0.000586	CcSEcCtD
L-DOPA—Nausea—Montelukast—allergic rhinitis	0.000104	0.000585	CcSEcCtD
L-DOPA—Syncope—Hydrocortisone—allergic rhinitis	0.000104	0.000584	CcSEcCtD
L-DOPA—Convulsion—Prednisolone—allergic rhinitis	0.000103	0.000578	CcSEcCtD
L-DOPA—Hypertension—Prednisolone—allergic rhinitis	0.000103	0.000576	CcSEcCtD
L-DOPA—Loss of consciousness—Hydrocortisone—allergic rhinitis	0.000102	0.000572	CcSEcCtD
L-DOPA—Arrhythmia—Betamethasone—allergic rhinitis	0.000102	0.000571	CcSEcCtD
L-DOPA—Arrhythmia—Dexamethasone—allergic rhinitis	0.000102	0.000571	CcSEcCtD
L-DOPA—Ill-defined disorder—Triamcinolone—allergic rhinitis	0.000102	0.000569	CcSEcCtD
L-DOPA—Ill-defined disorder—Methylprednisolone—allergic rhinitis	0.000101	0.000568	CcSEcCtD
L-DOPA—Alopecia—Dexamethasone—allergic rhinitis	0.000101	0.000565	CcSEcCtD
L-DOPA—Alopecia—Betamethasone—allergic rhinitis	0.000101	0.000565	CcSEcCtD
L-DOPA—Convulsion—Hydrocortisone—allergic rhinitis	0.000101	0.000564	CcSEcCtD
L-DOPA—Hypertension—Hydrocortisone—allergic rhinitis	0.0001	0.000562	CcSEcCtD
L-DOPA—Discomfort—Prednisolone—allergic rhinitis	0.0001	0.000561	CcSEcCtD
L-DOPA—Angioedema—Triamcinolone—allergic rhinitis	0.0001	0.00056	CcSEcCtD
L-DOPA—Angioedema—Methylprednisolone—allergic rhinitis	9.98e-05	0.000559	CcSEcCtD
L-DOPA—Malaise—Triamcinolone—allergic rhinitis	9.88e-05	0.000553	CcSEcCtD
L-DOPA—Anxiety—Hydrocortisone—allergic rhinitis	9.87e-05	0.000553	CcSEcCtD
L-DOPA—Malaise—Methylprednisolone—allergic rhinitis	9.85e-05	0.000552	CcSEcCtD
L-DOPA—Syncope—Triamcinolone—allergic rhinitis	9.82e-05	0.00055	CcSEcCtD
L-DOPA—Syncope—Methylprednisolone—allergic rhinitis	9.8e-05	0.000549	CcSEcCtD
L-DOPA—Discomfort—Hydrocortisone—allergic rhinitis	9.78e-05	0.000548	CcSEcCtD
L-DOPA—Oedema—Prednisolone—allergic rhinitis	9.72e-05	0.000544	CcSEcCtD
L-DOPA—Loss of consciousness—Triamcinolone—allergic rhinitis	9.63e-05	0.000539	CcSEcCtD
L-DOPA—Loss of consciousness—Methylprednisolone—allergic rhinitis	9.6e-05	0.000538	CcSEcCtD
L-DOPA—Shock—Prednisolone—allergic rhinitis	9.56e-05	0.000535	CcSEcCtD
L-DOPA—Cough—Triamcinolone—allergic rhinitis	9.56e-05	0.000535	CcSEcCtD
L-DOPA—Oedema—Hydrocortisone—allergic rhinitis	9.49e-05	0.000532	CcSEcCtD
L-DOPA—Convulsion—Triamcinolone—allergic rhinitis	9.49e-05	0.000531	CcSEcCtD
L-DOPA—Convulsion—Methylprednisolone—allergic rhinitis	9.47e-05	0.00053	CcSEcCtD
L-DOPA—Hypertension—Triamcinolone—allergic rhinitis	9.45e-05	0.000529	CcSEcCtD
L-DOPA—Hypertension—Methylprednisolone—allergic rhinitis	9.43e-05	0.000528	CcSEcCtD
L-DOPA—Hyperhidrosis—Prednisolone—allergic rhinitis	9.4e-05	0.000526	CcSEcCtD
L-DOPA—Shock—Hydrocortisone—allergic rhinitis	9.34e-05	0.000523	CcSEcCtD
L-DOPA—Anxiety—Methylprednisolone—allergic rhinitis	9.27e-05	0.000519	CcSEcCtD
L-DOPA—Ill-defined disorder—Betamethasone—allergic rhinitis	9.22e-05	0.000516	CcSEcCtD
L-DOPA—Ill-defined disorder—Dexamethasone—allergic rhinitis	9.22e-05	0.000516	CcSEcCtD
L-DOPA—Discomfort—Triamcinolone—allergic rhinitis	9.21e-05	0.000516	CcSEcCtD
L-DOPA—Discomfort—Methylprednisolone—allergic rhinitis	9.19e-05	0.000515	CcSEcCtD
L-DOPA—Hyperhidrosis—Hydrocortisone—allergic rhinitis	9.18e-05	0.000514	CcSEcCtD
L-DOPA—Dry mouth—Triamcinolone—allergic rhinitis	9.12e-05	0.000511	CcSEcCtD
L-DOPA—Angioedema—Dexamethasone—allergic rhinitis	9.08e-05	0.000508	CcSEcCtD
L-DOPA—Angioedema—Betamethasone—allergic rhinitis	9.08e-05	0.000508	CcSEcCtD
L-DOPA—Anorexia—Hydrocortisone—allergic rhinitis	9.05e-05	0.000507	CcSEcCtD
L-DOPA—Confusional state—Methylprednisolone—allergic rhinitis	8.99e-05	0.000504	CcSEcCtD
L-DOPA—Malaise—Dexamethasone—allergic rhinitis	8.96e-05	0.000502	CcSEcCtD
L-DOPA—Malaise—Betamethasone—allergic rhinitis	8.96e-05	0.000502	CcSEcCtD
L-DOPA—Oedema—Triamcinolone—allergic rhinitis	8.94e-05	0.0005	CcSEcCtD
L-DOPA—Syncope—Betamethasone—allergic rhinitis	8.91e-05	0.000499	CcSEcCtD
L-DOPA—Syncope—Dexamethasone—allergic rhinitis	8.91e-05	0.000499	CcSEcCtD
L-DOPA—Hypotension—Hydrocortisone—allergic rhinitis	8.87e-05	0.000497	CcSEcCtD
L-DOPA—Shock—Triamcinolone—allergic rhinitis	8.79e-05	0.000492	CcSEcCtD
L-DOPA—Insomnia—Prednisolone—allergic rhinitis	8.79e-05	0.000492	CcSEcCtD
L-DOPA—Shock—Methylprednisolone—allergic rhinitis	8.77e-05	0.000491	CcSEcCtD
L-DOPA—Loss of consciousness—Dexamethasone—allergic rhinitis	8.73e-05	0.000489	CcSEcCtD
L-DOPA—Loss of consciousness—Betamethasone—allergic rhinitis	8.73e-05	0.000489	CcSEcCtD
L-DOPA—Paraesthesia—Prednisolone—allergic rhinitis	8.73e-05	0.000489	CcSEcCtD
L-DOPA—Hyperhidrosis—Triamcinolone—allergic rhinitis	8.64e-05	0.000484	CcSEcCtD
L-DOPA—Hyperhidrosis—Methylprednisolone—allergic rhinitis	8.62e-05	0.000483	CcSEcCtD
L-DOPA—Convulsion—Betamethasone—allergic rhinitis	8.61e-05	0.000482	CcSEcCtD
L-DOPA—Convulsion—Dexamethasone—allergic rhinitis	8.61e-05	0.000482	CcSEcCtD
L-DOPA—Insomnia—Hydrocortisone—allergic rhinitis	8.58e-05	0.000481	CcSEcCtD
L-DOPA—Hypertension—Betamethasone—allergic rhinitis	8.58e-05	0.00048	CcSEcCtD
L-DOPA—Hypertension—Dexamethasone—allergic rhinitis	8.58e-05	0.00048	CcSEcCtD
L-DOPA—Paraesthesia—Hydrocortisone—allergic rhinitis	8.52e-05	0.000477	CcSEcCtD
L-DOPA—Anxiety—Dexamethasone—allergic rhinitis	8.43e-05	0.000472	CcSEcCtD
L-DOPA—Anxiety—Betamethasone—allergic rhinitis	8.43e-05	0.000472	CcSEcCtD
L-DOPA—Discomfort—Dexamethasone—allergic rhinitis	8.36e-05	0.000468	CcSEcCtD
L-DOPA—Discomfort—Betamethasone—allergic rhinitis	8.36e-05	0.000468	CcSEcCtD
L-DOPA—Dyspepsia—Hydrocortisone—allergic rhinitis	8.36e-05	0.000468	CcSEcCtD
L-DOPA—Hypotension—Methylprednisolone—allergic rhinitis	8.33e-05	0.000467	CcSEcCtD
L-DOPA—Pain—Prednisolone—allergic rhinitis	8.31e-05	0.000465	CcSEcCtD
L-DOPA—Decreased appetite—Hydrocortisone—allergic rhinitis	8.25e-05	0.000462	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	8.19e-05	0.000459	CcSEcCtD
L-DOPA—Fatigue—Hydrocortisone—allergic rhinitis	8.18e-05	0.000458	CcSEcCtD
L-DOPA—Pain—Hydrocortisone—allergic rhinitis	8.12e-05	0.000455	CcSEcCtD
L-DOPA—Oedema—Betamethasone—allergic rhinitis	8.11e-05	0.000454	CcSEcCtD
L-DOPA—Oedema—Dexamethasone—allergic rhinitis	8.11e-05	0.000454	CcSEcCtD
L-DOPA—Insomnia—Triamcinolone—allergic rhinitis	8.08e-05	0.000453	CcSEcCtD
L-DOPA—Insomnia—Methylprednisolone—allergic rhinitis	8.07e-05	0.000452	CcSEcCtD
L-DOPA—Paraesthesia—Triamcinolone—allergic rhinitis	8.03e-05	0.000449	CcSEcCtD
L-DOPA—Feeling abnormal—Prednisolone—allergic rhinitis	8.01e-05	0.000448	CcSEcCtD
L-DOPA—Paraesthesia—Methylprednisolone—allergic rhinitis	8.01e-05	0.000448	CcSEcCtD
L-DOPA—Shock—Betamethasone—allergic rhinitis	7.98e-05	0.000447	CcSEcCtD
L-DOPA—Shock—Dexamethasone—allergic rhinitis	7.98e-05	0.000447	CcSEcCtD
L-DOPA—Dyspnoea—Triamcinolone—allergic rhinitis	7.97e-05	0.000446	CcSEcCtD
L-DOPA—Thrombocytopenia—Betamethasone—allergic rhinitis	7.94e-05	0.000445	CcSEcCtD
L-DOPA—Thrombocytopenia—Dexamethasone—allergic rhinitis	7.94e-05	0.000445	CcSEcCtD
L-DOPA—Dyspepsia—Triamcinolone—allergic rhinitis	7.87e-05	0.000441	CcSEcCtD
L-DOPA—Dyspepsia—Methylprednisolone—allergic rhinitis	7.85e-05	0.00044	CcSEcCtD
L-DOPA—Hyperhidrosis—Dexamethasone—allergic rhinitis	7.84e-05	0.000439	CcSEcCtD
L-DOPA—Hyperhidrosis—Betamethasone—allergic rhinitis	7.84e-05	0.000439	CcSEcCtD
L-DOPA—Feeling abnormal—Hydrocortisone—allergic rhinitis	7.82e-05	0.000438	CcSEcCtD
L-DOPA—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	7.76e-05	0.000435	CcSEcCtD
L-DOPA—Anorexia—Betamethasone—allergic rhinitis	7.73e-05	0.000433	CcSEcCtD
L-DOPA—Anorexia—Dexamethasone—allergic rhinitis	7.73e-05	0.000433	CcSEcCtD
L-DOPA—Urticaria—Prednisolone—allergic rhinitis	7.72e-05	0.000432	CcSEcCtD
L-DOPA—Fatigue—Triamcinolone—allergic rhinitis	7.71e-05	0.000432	CcSEcCtD
L-DOPA—Fatigue—Methylprednisolone—allergic rhinitis	7.69e-05	0.000431	CcSEcCtD
L-DOPA—Pain—Triamcinolone—allergic rhinitis	7.64e-05	0.000428	CcSEcCtD
L-DOPA—Hypotension—Betamethasone—allergic rhinitis	7.58e-05	0.000424	CcSEcCtD
L-DOPA—Hypotension—Dexamethasone—allergic rhinitis	7.58e-05	0.000424	CcSEcCtD
L-DOPA—Urticaria—Hydrocortisone—allergic rhinitis	7.54e-05	0.000422	CcSEcCtD
L-DOPA—Abdominal pain—Hydrocortisone—allergic rhinitis	7.5e-05	0.00042	CcSEcCtD
L-DOPA—Feeling abnormal—Triamcinolone—allergic rhinitis	7.37e-05	0.000412	CcSEcCtD
L-DOPA—Feeling abnormal—Methylprednisolone—allergic rhinitis	7.35e-05	0.000412	CcSEcCtD
L-DOPA—Insomnia—Betamethasone—allergic rhinitis	7.33e-05	0.000411	CcSEcCtD
L-DOPA—Insomnia—Dexamethasone—allergic rhinitis	7.33e-05	0.000411	CcSEcCtD
L-DOPA—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	7.29e-05	0.000408	CcSEcCtD
L-DOPA—Paraesthesia—Betamethasone—allergic rhinitis	7.28e-05	0.000408	CcSEcCtD
L-DOPA—Paraesthesia—Dexamethasone—allergic rhinitis	7.28e-05	0.000408	CcSEcCtD
L-DOPA—Hypersensitivity—Prednisolone—allergic rhinitis	7.16e-05	0.000401	CcSEcCtD
L-DOPA—Dyspepsia—Dexamethasone—allergic rhinitis	7.14e-05	0.0004	CcSEcCtD
L-DOPA—Dyspepsia—Betamethasone—allergic rhinitis	7.14e-05	0.0004	CcSEcCtD
L-DOPA—Urticaria—Triamcinolone—allergic rhinitis	7.1e-05	0.000398	CcSEcCtD
L-DOPA—Urticaria—Methylprednisolone—allergic rhinitis	7.08e-05	0.000397	CcSEcCtD
L-DOPA—Abdominal pain—Methylprednisolone—allergic rhinitis	7.05e-05	0.000395	CcSEcCtD
L-DOPA—Decreased appetite—Dexamethasone—allergic rhinitis	7.05e-05	0.000395	CcSEcCtD
L-DOPA—Decreased appetite—Betamethasone—allergic rhinitis	7.05e-05	0.000395	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	7e-05	0.000392	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Betamethasone—allergic rhinitis	7e-05	0.000392	CcSEcCtD
L-DOPA—Hypersensitivity—Hydrocortisone—allergic rhinitis	6.99e-05	0.000392	CcSEcCtD
L-DOPA—Fatigue—Betamethasone—allergic rhinitis	6.99e-05	0.000392	CcSEcCtD
L-DOPA—Fatigue—Dexamethasone—allergic rhinitis	6.99e-05	0.000392	CcSEcCtD
L-DOPA—Pain—Betamethasone—allergic rhinitis	6.93e-05	0.000388	CcSEcCtD
L-DOPA—Pain—Dexamethasone—allergic rhinitis	6.93e-05	0.000388	CcSEcCtD
L-DOPA—Asthenia—Hydrocortisone—allergic rhinitis	6.81e-05	0.000381	CcSEcCtD
L-DOPA—Pruritus—Hydrocortisone—allergic rhinitis	6.72e-05	0.000376	CcSEcCtD
L-DOPA—Feeling abnormal—Dexamethasone—allergic rhinitis	6.68e-05	0.000374	CcSEcCtD
L-DOPA—Feeling abnormal—Betamethasone—allergic rhinitis	6.68e-05	0.000374	CcSEcCtD
L-DOPA—Gastrointestinal pain—Betamethasone—allergic rhinitis	6.63e-05	0.000371	CcSEcCtD
L-DOPA—Gastrointestinal pain—Dexamethasone—allergic rhinitis	6.63e-05	0.000371	CcSEcCtD
L-DOPA—Hypersensitivity—Triamcinolone—allergic rhinitis	6.58e-05	0.000369	CcSEcCtD
L-DOPA—Hypersensitivity—Methylprednisolone—allergic rhinitis	6.57e-05	0.000368	CcSEcCtD
L-DOPA—Diarrhoea—Hydrocortisone—allergic rhinitis	6.49e-05	0.000364	CcSEcCtD
L-DOPA—Urticaria—Betamethasone—allergic rhinitis	6.44e-05	0.000361	CcSEcCtD
L-DOPA—Urticaria—Dexamethasone—allergic rhinitis	6.44e-05	0.000361	CcSEcCtD
L-DOPA—Dizziness—Prednisolone—allergic rhinitis	6.43e-05	0.00036	CcSEcCtD
L-DOPA—Asthenia—Triamcinolone—allergic rhinitis	6.41e-05	0.000359	CcSEcCtD
L-DOPA—Abdominal pain—Betamethasone—allergic rhinitis	6.41e-05	0.000359	CcSEcCtD
L-DOPA—Abdominal pain—Dexamethasone—allergic rhinitis	6.41e-05	0.000359	CcSEcCtD
L-DOPA—Asthenia—Methylprednisolone—allergic rhinitis	6.4e-05	0.000358	CcSEcCtD
L-DOPA—Pruritus—Triamcinolone—allergic rhinitis	6.32e-05	0.000354	CcSEcCtD
L-DOPA—Pruritus—Methylprednisolone—allergic rhinitis	6.31e-05	0.000353	CcSEcCtD
L-DOPA—Dizziness—Hydrocortisone—allergic rhinitis	6.28e-05	0.000351	CcSEcCtD
L-DOPA—Rash—Prednisolone—allergic rhinitis	6.13e-05	0.000343	CcSEcCtD
L-DOPA—Dermatitis—Prednisolone—allergic rhinitis	6.12e-05	0.000343	CcSEcCtD
L-DOPA—Diarrhoea—Methylprednisolone—allergic rhinitis	6.1e-05	0.000342	CcSEcCtD
L-DOPA—Headache—Prednisolone—allergic rhinitis	6.09e-05	0.000341	CcSEcCtD
L-DOPA—Vomiting—Hydrocortisone—allergic rhinitis	6.04e-05	0.000338	CcSEcCtD
L-DOPA—Rash—Hydrocortisone—allergic rhinitis	5.98e-05	0.000335	CcSEcCtD
L-DOPA—Dermatitis—Hydrocortisone—allergic rhinitis	5.98e-05	0.000335	CcSEcCtD
L-DOPA—Headache—Hydrocortisone—allergic rhinitis	5.95e-05	0.000333	CcSEcCtD
L-DOPA—Dizziness—Triamcinolone—allergic rhinitis	5.91e-05	0.000331	CcSEcCtD
L-DOPA—Dizziness—Methylprednisolone—allergic rhinitis	5.9e-05	0.00033	CcSEcCtD
L-DOPA—Asthenia—Dexamethasone—allergic rhinitis	5.82e-05	0.000326	CcSEcCtD
L-DOPA—Asthenia—Betamethasone—allergic rhinitis	5.82e-05	0.000326	CcSEcCtD
L-DOPA—Nausea—Prednisolone—allergic rhinitis	5.77e-05	0.000323	CcSEcCtD
L-DOPA—Pruritus—Dexamethasone—allergic rhinitis	5.74e-05	0.000321	CcSEcCtD
L-DOPA—Pruritus—Betamethasone—allergic rhinitis	5.74e-05	0.000321	CcSEcCtD
L-DOPA—Vomiting—Triamcinolone—allergic rhinitis	5.68e-05	0.000318	CcSEcCtD
L-DOPA—Vomiting—Methylprednisolone—allergic rhinitis	5.67e-05	0.000318	CcSEcCtD
L-DOPA—Nausea—Hydrocortisone—allergic rhinitis	5.64e-05	0.000316	CcSEcCtD
L-DOPA—Rash—Triamcinolone—allergic rhinitis	5.64e-05	0.000316	CcSEcCtD
L-DOPA—Dermatitis—Triamcinolone—allergic rhinitis	5.63e-05	0.000315	CcSEcCtD
L-DOPA—Rash—Methylprednisolone—allergic rhinitis	5.62e-05	0.000315	CcSEcCtD
L-DOPA—Dermatitis—Methylprednisolone—allergic rhinitis	5.62e-05	0.000315	CcSEcCtD
L-DOPA—Headache—Triamcinolone—allergic rhinitis	5.6e-05	0.000314	CcSEcCtD
L-DOPA—Headache—Methylprednisolone—allergic rhinitis	5.59e-05	0.000313	CcSEcCtD
L-DOPA—Diarrhoea—Betamethasone—allergic rhinitis	5.55e-05	0.000311	CcSEcCtD
L-DOPA—Diarrhoea—Dexamethasone—allergic rhinitis	5.55e-05	0.000311	CcSEcCtD
L-DOPA—Dizziness—Dexamethasone—allergic rhinitis	5.36e-05	0.0003	CcSEcCtD
L-DOPA—Dizziness—Betamethasone—allergic rhinitis	5.36e-05	0.0003	CcSEcCtD
L-DOPA—Nausea—Triamcinolone—allergic rhinitis	5.31e-05	0.000297	CcSEcCtD
L-DOPA—Nausea—Methylprednisolone—allergic rhinitis	5.3e-05	0.000297	CcSEcCtD
L-DOPA—Vomiting—Dexamethasone—allergic rhinitis	5.16e-05	0.000289	CcSEcCtD
L-DOPA—Vomiting—Betamethasone—allergic rhinitis	5.16e-05	0.000289	CcSEcCtD
L-DOPA—Rash—Betamethasone—allergic rhinitis	5.11e-05	0.000286	CcSEcCtD
L-DOPA—Rash—Dexamethasone—allergic rhinitis	5.11e-05	0.000286	CcSEcCtD
L-DOPA—Dermatitis—Dexamethasone—allergic rhinitis	5.11e-05	0.000286	CcSEcCtD
L-DOPA—Dermatitis—Betamethasone—allergic rhinitis	5.11e-05	0.000286	CcSEcCtD
L-DOPA—Headache—Betamethasone—allergic rhinitis	5.08e-05	0.000284	CcSEcCtD
L-DOPA—Headache—Dexamethasone—allergic rhinitis	5.08e-05	0.000284	CcSEcCtD
L-DOPA—Nausea—Dexamethasone—allergic rhinitis	4.82e-05	0.00027	CcSEcCtD
L-DOPA—Nausea—Betamethasone—allergic rhinitis	4.82e-05	0.00027	CcSEcCtD
L-DOPA—PSIP1—Early Phase of HIV Life Cycle—CD4—allergic rhinitis	1.38e-05	0.122	CbGpPWpGaD
L-DOPA—PSIP1—Host Interactions of HIV factors—CD4—allergic rhinitis	2.37e-06	0.021	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—IL13—allergic rhinitis	2.29e-06	0.0203	CbGpPWpGaD
L-DOPA—PSIP1—HIV Life Cycle—CD4—allergic rhinitis	2.23e-06	0.0198	CbGpPWpGaD
L-DOPA—DDC—Dopaminergic Neurogenesis—TGFB1—allergic rhinitis	2.19e-06	0.0193	CbGpPWpGaD
L-DOPA—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	2.17e-06	0.0192	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	2.11e-06	0.0187	CbGpPWpGaD
L-DOPA—DRD5—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	2.01e-06	0.0178	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.73e-06	0.0153	CbGpPWpGaD
L-DOPA—DRD4—G alpha (i) signalling events—PTGDR2—allergic rhinitis	1.6e-06	0.0142	CbGpPWpGaD
L-DOPA—DRD5—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.58e-06	0.014	CbGpPWpGaD
L-DOPA—DDC—Circadian rythm related genes—ADIPOQ—allergic rhinitis	1.55e-06	0.0137	CbGpPWpGaD
L-DOPA—PSIP1—HIV Infection—CD4—allergic rhinitis	1.54e-06	0.0136	CbGpPWpGaD
L-DOPA—DRD4—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.49e-06	0.0132	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—IL10—allergic rhinitis	1.43e-06	0.0127	CbGpPWpGaD
L-DOPA—DRD3—G alpha (i) signalling events—PTGDR2—allergic rhinitis	1.42e-06	0.0126	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.35e-06	0.012	CbGpPWpGaD
L-DOPA—DRD1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.34e-06	0.0118	CbGpPWpGaD
L-DOPA—DRD3—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.32e-06	0.0117	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—PTGDR2—allergic rhinitis	1.31e-06	0.0116	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.31e-06	0.0116	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.27e-06	0.0113	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—IL5—allergic rhinitis	1.23e-06	0.0109	CbGpPWpGaD
L-DOPA—DRD4—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.17e-06	0.0103	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.15e-06	0.0101	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.13e-06	0.01	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—PTGDR2—allergic rhinitis	1.09e-06	0.00963	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—IL5—allergic rhinitis	1.07e-06	0.00947	CbGpPWpGaD
L-DOPA—DRD1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.05e-06	0.00929	CbGpPWpGaD
L-DOPA—DRD3—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.04e-06	0.00917	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—CYSLTR1—allergic rhinitis	1.03e-06	0.00912	CbGpPWpGaD
L-DOPA—DRD2—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.01e-06	0.00894	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	9.99e-07	0.00884	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—CCL11—allergic rhinitis	9.96e-07	0.00881	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—PTGDR2—allergic rhinitis	9.7e-07	0.00858	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	9.65e-07	0.00854	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	9.5e-07	0.00841	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—ADIPOQ—allergic rhinitis	9e-07	0.00796	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	9e-07	0.00796	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	8.88e-07	0.00785	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—PTGDR2—allergic rhinitis	8.73e-07	0.00772	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	8.69e-07	0.00769	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	8.66e-07	0.00766	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—PTGDR2—allergic rhinitis	8.61e-07	0.00762	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	8.57e-07	0.00759	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—ADIPOQ—allergic rhinitis	8.1e-07	0.00717	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—ADIPOQ—allergic rhinitis	7.99e-07	0.00707	CbGpPWpGaD
L-DOPA—DRD2—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	7.93e-07	0.00701	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—CYSLTR1—allergic rhinitis	7.61e-07	0.00673	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—PTGDR2—allergic rhinitis	7.43e-07	0.00657	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—CCL11—allergic rhinitis	7.35e-07	0.0065	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—TAC1—allergic rhinitis	7.24e-07	0.0064	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	7.02e-07	0.00621	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	7.01e-07	0.0062	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—CYSLTR1—allergic rhinitis	6.85e-07	0.00606	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	6.79e-07	0.00601	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—CYSLTR1—allergic rhinitis	6.76e-07	0.00598	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—PTGDR2—allergic rhinitis	6.74e-07	0.00597	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—CCL11—allergic rhinitis	6.62e-07	0.00585	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—PTGDR2—allergic rhinitis	6.59e-07	0.00583	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	6.56e-07	0.0058	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—CCL11—allergic rhinitis	6.53e-07	0.00578	CbGpPWpGaD
L-DOPA—PSIP1—Disease—SMAD3—allergic rhinitis	6.41e-07	0.00567	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	6.31e-07	0.00559	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	6.23e-07	0.00551	CbGpPWpGaD
L-DOPA—CYP2D6—Melatonin metabolism and effects—NFKB1—allergic rhinitis	6.2e-07	0.00549	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—ADIPOQ—allergic rhinitis	6.12e-07	0.00541	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.83e-07	0.00516	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—PTGDR2—allergic rhinitis	5.48e-07	0.00485	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—TAC1—allergic rhinitis	5.34e-07	0.00473	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CYSLTR1—allergic rhinitis	5.29e-07	0.00468	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CYSLTR1—allergic rhinitis	5.17e-07	0.00458	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CCL11—allergic rhinitis	5.11e-07	0.00452	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CCL11—allergic rhinitis	5e-07	0.00442	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—PTGDR2—allergic rhinitis	4.98e-07	0.0044	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—PTGDR2—allergic rhinitis	4.93e-07	0.00437	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—PTGDR2—allergic rhinitis	4.87e-07	0.00431	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—TAC1—allergic rhinitis	4.81e-07	0.00425	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	4.77e-07	0.00422	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—TAC1—allergic rhinitis	4.74e-07	0.0042	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—PTGDR2—allergic rhinitis	4.48e-07	0.00396	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—PTGDR2—allergic rhinitis	4.42e-07	0.00391	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CYSLTR1—allergic rhinitis	4.3e-07	0.00381	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—TAC1—allergic rhinitis	4.09e-07	0.00362	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PTGDR2—allergic rhinitis	3.98e-07	0.00352	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.91e-07	0.00346	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.87e-07	0.00343	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.82e-07	0.00338	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—IL5—allergic rhinitis	3.8e-07	0.00336	CbGpPWpGaD
L-DOPA—PSIP1—Disease—CD4—allergic rhinitis	3.78e-07	0.00334	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CCL11—allergic rhinitis	3.77e-07	0.00334	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—PTGDR2—allergic rhinitis	3.73e-07	0.0033	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—TAC1—allergic rhinitis	3.71e-07	0.00329	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—TGFB1—allergic rhinitis	3.66e-07	0.00323	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—TAC1—allergic rhinitis	3.63e-07	0.00321	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.52e-07	0.00311	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.47e-07	0.00307	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL5—allergic rhinitis	3.45e-07	0.00305	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CCL11—allergic rhinitis	3.4e-07	0.003	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PTGDR2—allergic rhinitis	3.38e-07	0.00299	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CCL11—allergic rhinitis	3.35e-07	0.00296	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—TGFB1—allergic rhinitis	3.19e-07	0.00282	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CYSLTR1—allergic rhinitis	3.13e-07	0.00277	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CCL11—allergic rhinitis	3.02e-07	0.00267	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—TAC1—allergic rhinitis	3.02e-07	0.00267	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PTGDR2—allergic rhinitis	2.94e-07	0.0026	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.92e-07	0.00259	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—IL5—allergic rhinitis	2.81e-07	0.00248	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—TAC1—allergic rhinitis	2.74e-07	0.00242	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—TAC1—allergic rhinitis	2.72e-07	0.0024	CbGpPWpGaD
L-DOPA—PSIP1—Disease—TGFB1—allergic rhinitis	2.71e-07	0.0024	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—TAC1—allergic rhinitis	2.68e-07	0.00237	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.65e-07	0.00235	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PTGDR2—allergic rhinitis	2.65e-07	0.00234	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PTGDR2—allergic rhinitis	2.61e-07	0.00231	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCL11—allergic rhinitis	2.56e-07	0.00227	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL5—allergic rhinitis	2.55e-07	0.00225	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—IL5—allergic rhinitis	2.53e-07	0.00223	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—IL5—allergic rhinitis	2.49e-07	0.00221	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—TAC1—allergic rhinitis	2.47e-07	0.00218	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—TAC1—allergic rhinitis	2.43e-07	0.00215	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CYSLTR1—allergic rhinitis	2.31e-07	0.00204	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL5—allergic rhinitis	2.29e-07	0.00203	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL5—allergic rhinitis	2.26e-07	0.002	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCL11—allergic rhinitis	2.23e-07	0.00197	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TAC1—allergic rhinitis	2.19e-07	0.00194	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CYSLTR1—allergic rhinitis	2.08e-07	0.00184	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—TAC1—allergic rhinitis	2.05e-07	0.00181	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CYSLTR1—allergic rhinitis	2.05e-07	0.00181	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL5—allergic rhinitis	2.04e-07	0.0018	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCL11—allergic rhinitis	2.01e-07	0.00177	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PTGDR2—allergic rhinitis	2e-07	0.00177	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCL11—allergic rhinitis	1.98e-07	0.00175	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—IL5—allergic rhinitis	1.91e-07	0.00169	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—TAC1—allergic rhinitis	1.86e-07	0.00165	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL5—allergic rhinitis	1.73e-07	0.00153	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TAC1—allergic rhinitis	1.62e-07	0.00143	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CYSLTR1—allergic rhinitis	1.57e-07	0.00139	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL11—allergic rhinitis	1.51e-07	0.00134	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL5—allergic rhinitis	1.51e-07	0.00133	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TAC1—allergic rhinitis	1.46e-07	0.00129	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TAC1—allergic rhinitis	1.44e-07	0.00127	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—SMAD3—allergic rhinitis	1.44e-07	0.00127	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL5—allergic rhinitis	1.35e-07	0.0012	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL5—allergic rhinitis	1.34e-07	0.00118	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TAC1—allergic rhinitis	1.1e-07	0.000974	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SMAD3—allergic rhinitis	1.06e-07	0.000937	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL5—allergic rhinitis	1.02e-07	0.000905	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SMAD3—allergic rhinitis	9.54e-08	0.000844	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SMAD3—allergic rhinitis	9.41e-08	0.000833	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NFKB1—allergic rhinitis	7.3e-08	0.000646	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SMAD3—allergic rhinitis	7.2e-08	0.000637	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TGFB1—allergic rhinitis	6.08e-08	0.000538	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NFKB1—allergic rhinitis	5.38e-08	0.000476	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NFKB1—allergic rhinitis	4.85e-08	0.000429	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NFKB1—allergic rhinitis	4.78e-08	0.000423	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TGFB1—allergic rhinitis	4.49e-08	0.000397	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TGFB1—allergic rhinitis	4.04e-08	0.000357	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TGFB1—allergic rhinitis	3.98e-08	0.000353	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NFKB1—allergic rhinitis	3.66e-08	0.000324	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TGFB1—allergic rhinitis	3.05e-08	0.00027	CbGpPWpGaD
